Similar articles

• Trial with a new anxiolytic antidepressant, butriptyline hydrochloride (AY-62014) Evadyne.

  Perez de Francisco C, Nieto Gomez D, Castilla J, Torres A, Avalos C. Perez de Francisco C, et al. J Med. 1971;2(5):316-21. J Med. 1971. PMID: 4948369 Clinical Trial. No abstract available.
• Preliminary clinical results in the treatment of psychoneurotic depression with butriptyline.

  Grattarola FR, Morgando E, Ravarino G. Grattarola FR, et al. J Med. 1971;2(5):327-30. J Med. 1971. PMID: 4948371 Clinical Trial. No abstract available.
• Psychopharmacologic investigation with butriptyline hydrochloride (AY-62014) in patients with various depressive disturbances.

  Saldaña OH, Hernández J. Saldaña OH, et al. J Med. 1971;2(5):309-10. J Med. 1971. PMID: 4948367 Clinical Trial. No abstract available.
• [Psychopharmacological agent in anxiety states].

  Dale J. Dale J. Nord Med. 1970 Feb 19;83(8):225-31. Nord Med. 1970. PMID: 4910678 Review. Norwegian. No abstract available.
• Clinical guidance on the use of antidepressant medications in children and adolescents.

  Lyndon B, Rowe L, Fraser A, Efron D, Walter G, Wilson I, Newman L, Silove N; Royal Australian and New Zealand College of Psychiatrists; Royal Australasian College of Physicians; Royal Australian College of General Practitioners. Lyndon B, et al. Aust Fam Physician. 2005 Sep;34(9):777-8. Aust Fam Physician. 2005. PMID: 16184211 Review. No abstract available.